Screener
NeoGenomics NEO D&A
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net loss | $(14,868) | $(71,015) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
| Depreciation | 17,356 | 18,506 |
| Amortization of intangibles | 15,267 | 16,486 |
| Stock-based compensation | 17,852 | 22,968 |
| Non-cash operating lease expense | 3,226 | 3,346 |
| Non-cash finance lease amortization | 322 | 7 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's D&A?
- NeoGenomics (NEO) reported D&A of $8.58M in Q2 2026.
- How has NeoGenomics's D&A changed year-over-year?
- NeoGenomics's D&A decreased by 6.2% year-over-year, from $9.14M to $8.58M.
- What is the long-term trend for NeoGenomics's D&A?
- Over 4 years (2021 to 2025), NeoGenomics's D&A has grown at a 4.5% compound annual growth rate (CAGR), from $30.19M to $36.07M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about NeoGenomics's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude